Related Experiment Video
Updated: May 16, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Functional disability in medication management and driving among individuals with HIV: a 1-year follow-up study
April D Thames1, Alyssa Arentoft, Monica Rivera-Mindt
1Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, Los Angeles, CA 90095, USA. athames@mednet.ucla.edu
Insights
Cognitive deficits in people with HIV (Human Immunodeficiency Virus) can predict future challenges with daily tasks. Lower baseline learning, memory, and executive function are linked to medication management difficulties.
Area of Science:
- Neuropsychology
- Infectious Diseases
- Gerontology
Background:
- Cognitive deficits are prevalent in approximately 50% of individuals with HIV.
- These deficits can significantly impair social and occupational functioning.
- Understanding the link between cognition and daily function is crucial for intervention.
Purpose of the Study:
- To longitudinally examine the relationship between cognitive factors and functional deficits in medication management and driving ability in HIV+ individuals.
- To determine if baseline cognitive performance predicts later functional disability.
- To identify specific cognitive domains most predictive of functional decline.
Main Methods:
- A 1-year longitudinal study of 101 HIV+ participants.
- Assessment of cognitive functions including learning/memory, executive functioning, and information processing speed.
- Laboratory-based functional tasks: Medication Management Task-Revised (MMT-R) and a PC-based driving simulator.
- Classification of participants into functionally
- stable
- and
- disabled
- groups for each task.
Main Results:
- Lower baseline performance in learning/memory and executive functioning predicted functional disability in medication management at follow-up.
- Poor baseline speed of information processing was associated with deficits in driving ability at follow-up.
- Cognitive decline at baseline significantly predicted downstream functional disability.
Conclusions:
- Baseline cognitive functioning is a significant predictor of future functional disability in individuals with HIV.
- Deficits in learning/memory and information processing speed are particularly indicative of challenges in medication management and driving.
- These findings highlight the importance of cognitive screening for functional assessment in HIV care.
Abstract:
Approximately 50% of individuals with HIV report cognitive deficits that can affect social or occupational functioning. The present study used a longitudinal design (1 year) to examine the relationship between cognitive factors and incidental functional deficits in medication management and driving ability among a cohort of 101 HIV+ participants. Participants were classified into groups of functionally "stable" and "disabled" for each laboratory-based functional task (i.e., Medication Management Task-Revised, MMT-R, and PC-based driving simulator). We hypothesized that participants who exhibited a functional deficit in either MMT-R or driving at follow-up assessment would demonstrate significantly poorer baseline cognitive performance at study entry than participants who remained functionally stable. As hypothesized, participants who demonstrated significantly lower baseline performance in learning/memory and executive functioning also demonstrated functional disability on the MMT-R at follow-up when compared to functionally stable participants. Poor baseline performance in speed of information processing was associated with a deficit in driving ability at follow-up assessment. Our results suggest that lower baseline cognitive functioning predicts downstream functional disability, and that deficits in learning/memory and information processing speed are particularly predictive of deficits in medication management and driving ability.
More Related Videos
07:27Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Therapeutic Drug Monitoring: Affecting Factors
Drug Dosing: Geriatric Patients
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Retrovirus Life Cycles
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test